Briacell Therapeutics Corp. Common Shares

BCTX

...

BCTX: BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in advanced metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advanced-stage breast cancer by matching the patient's HLA type.

Show BCTX Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of BCTX by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by BCTX's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on BCTX's company Twitter account

WallStreetBets

Number of mentions of BCTX in WallStreetBets Daily Discussion

BCTX News

Recent insights relating to BCTX

CNBC Recommendations

Recent picks made for BCTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BCTX

Corporate Flights

Flights by private jets registered to BCTX